P1543: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES THAT NEED VASOACTIVE SUPPORT – SINGLE CENTER STUDY

por Vitkon, Roy, Halak, Noa, Avivi, Irit
Publicado 2023

PB2288: INCIDENCE OF NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN’S LYMPHOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN ISRAEL - A SINGLE CENTER RETROSPECTIVE STUDY

por Bronstein, Yotam, Feigin, Eugene, Avivi, Irit, Joffe, Erel, Perry, Chava
Publicado 2023

Dendritic Cell Cancer Vaccines: From the Bench to the Bedside

por Katz, Tamar, Avivi, Irit, Benyamini, Noam, Rosenblatt, Jacalyn, Avigan, David
Publicado 2014

Predictors of Early and Late Mortality for Patients with Hematologic Malignancy and Invasive Mold Disease

por Yashphe, Eva L., Ram, Ron, Avivi, Irit, Ben-Ami, Ronen
Publicado 2021

Remote Digital Microscopy Improves Hematology Laboratory Workflow by Reducing Peripheral Blood Smear Analysis Turnaround Time

por Katz, Ben-Zion, Benisty, Dan, Sayegh, Yael, Lamm, Inna, Avivi, Irit
Publicado 2022

REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection

por Bronstein, Yotam, Avivi, Irit, Cohen, Yael C, Feigin, Eugene, Perry, Chava, Herishanu, Yair
Publicado 2022

P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY...

por Fridberg, Gil, Shragai, Tamir, Melamed, Natan, Trestman, Svetlana, Vaxman, Iuliana, Avivi, Irit, Cohen, Yael
Publicado 2023

Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma

por Atar, Or, Ram, Ron, Avivi, Irit, Amit, Odelia, Vitkon, Roy, Luttwak, Efrat, Bar-On, Yael, Gidron, Yori
Publicado 2023

The Role of Extracellular Vesicles (EVs) in Chronic Graft vs. Host Disease, and the Potential Function of Placental Cell-Derived EVs as a Therapeutic Tool

por Zavaro, Mor, Dangot, Ayelet, Bar-Lev, Tali Hana, Amit, Odelia, Avivi, Irit, Ram, Ron, Aharon, Anat
Publicado 2023

New Rising Infection: Human Herpesvirus 6 Is Frequent in Myeloma Patients Undergoing Autologous Stem Cell Transplantation after Induction Therapy with Bortezomib

por Horowitz, Netanel, Oren, Ilana, Lavi, Noa, Zuckerman, Tsila, Benyamini, Noam, Kra-Oz, Zipi, Held, Viki, Avivi, Irit
Publicado 2012

Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy

por Cohen, Dan, Hazut Krauthammer, Shir, Cohen, Yael C., Perry, Chava, Avivi, Irit, Herishanu, Yair, Even-Sapir, Einat
Publicado 2021

Characterization of extracellular vesicles in COVID-19 infection during pregnancy

por Dangot, Ayelet, Zavaro, Mor, Bar-Lev, Tali Hana, Bannon, Lian, Zilberman, Ayala, Pickholz, Eliana, Avivi, Irit, Aharon, Anat
Publicado 2023

Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma

por Markus, Efrat, Trestman, Svetlana, Cohen, Yael, Angel, Yoel, Sofer, Yael, Mittelman, Moshe, Avivi, Irit, Stern, Naftali, Izkhakov, Elena
Publicado 2020

Is There a Role for [(18)F]FDG PET-CT in Staging MALT Lymphoma?

por Cohen, Dan, Perry, Chava, Hazut-Krauthammer, Shir, Kesler, Mikhail, Herishanu, Yair, Luttwak, Efrat, Even-Sapir, Einat, Avivi, Irit
Publicado 2022

Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images

por Perry, Chava, Greenberg, Orli, Haberman, Shira, Herskovitz, Neta, Gazy, Inbal, Avinoam, Assaf, Paz-Yaacov, Nurit, Hershkovitz, Dov, Avivi, Irit
Publicado 2023

Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience

por Ram, Ron, Scheid, Christof, Amit, Odelia, Chemnitz, Jens Markus, Moshe, Yakir, Hallek, Michael, Wolf, Dominik, Avivi, Irit, Holtick, Udo
Publicado 2019

Extracellular Vesicles of COVID-19 Patients Reflect Inflammation, Thrombogenicity, and Disease Severity

por Aharon, Anat, Dangot, Ayelet, Kinaani, Fadi, Zavaro, Mor, Bannon, Lian, Bar-lev, Tali, Keren-Politansky, Anat, Avivi, Irit, Jacob, Giris
Publicado 2023

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

por Shapiro, Mika, Herishanu, Yair, Katz, Ben-Zion, Dezorella, Nili, Sun, Clare, Kay, Sigi, Polliack, Aaron, Avivi, Irit, Wiestner, Adrian, Perry, Chava
Publicado 2017

Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19

por Sarid, Nadav, Mann, Shir, Herishanu, Yair, Perry, Chava, Cohen, Yael C, Passage, Inna, Neaman, Miriam, Benyamini, Noam, Jean, Maayan, Avivi, Irit
Publicado 2021

Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia

por Herishanu, Yair, Avivi, Irit, Levi, Shai, Shefer, Gabi, Bronstein, Yotam, Moshiashvili, Miguel Morales, Ziv, Tomer, Scarfò, Lydia, Perry, Chava, Ghia, Paolo
Publicado 2022